22
Mar
The omicron subvariant BA.2 is continuing to reap ground in the U.S., in accordance to Covid-19 assessments sequenced over the closing two weeks. Helix, a San Diego-based genomics firm, has been staring at the BA.2 variant since it first popped up in the U.S. in early January. Although it was once initially sluggish to take hold, Helix now estimates that 50% to 70% of all Covid instances nationwide are BA.2. Will Lee, Helix's chief science officer, said this type of surveillance is imperative and can help arm the U.S. fitness care machine towards future variants. Data from the U.K. -…